Showing results (61-70 of 272) with videos related to
Sort By:
Pageof 28
The Journal of Clinical Investigation|November 15, 2021
RAF1 amplification: an exemplar of MAPK pathway activation in urothelial carcinomaSean Clark-Garvey, William Y KimClinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2013
Stearoyl co-A desaturase 1 as a ccRCC therapeutic target: death by stressJanet Y Leung, William Y KimThe Journal of Clinical Investigation|February 3, 2015
The next steps in next-gen sequencing of cancer genomesD Neil Hayes, William Y KimJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Role of VHL gene mutation in human cancerWilliam Y Kim, William G KaelinCell|October 24, 2006
The regulation of INK4/ARF in cancer and agingWilliam Y Kim, Norman E SharplessCancer Cell|April 9, 2008
VHL inactivation: a new road to senescenceWilliam Y Kim, Norman E SharplessClinical Genitourinary Cancer|April 11, 2021
Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder CancerTrevor J Royce, Yuan Liu, Matthew I Milowsky, et al.Cancer Discovery|August 3, 2017
Bap1 and Pbrm1: Determinants of Tumor Grade and mTOR Activation in VHL-Deficient Mouse Models of Renal Cell CarcinomaJanet Y Leung, William Y KimSeminars in Oncology|October 19, 2006
Molecular pathways in renal cell carcinoma--rationale for targeted treatmentWilliam Y Kim, William G KaelinPageof 28